Background Patients hospitalized with COVID-19 experienced an increased risk of venous
thromboembolism. Aims To evaluate the effect of chronic oral anticoagulation (OAC) …

Purpose The clinical course of COVID-19 may be complicated by acute respiratory distress
syndrome (ARDS) and thromboembolic events, which are associated with high risk of …

Background. Most evidence regarding anticoagulation and COVID‐19 refers to the
hospitalization setting, but the role of oral anticoagulation (OAC) before hospital admission …

Background: Hypercoagulability and thromboembolic events are associated with poor
prognosis in coronavirus disease 2019 (COVID-19) patients. Whether chronic oral …

Abstract Coronavirus disease 2019 (COVID-19) is associated with a high incidence of
venous and arterial thromboembolic events. The role of anticoagulation (AC) prior to …

Aims Coagulopathy and venous thromboembolism are common findings in coronavirus
disease 2019 (COVID-19) and are associated with poor outcome. Timely initiation of …

Abstract Background Coronavirus disease 2019 (COVID-19) global pandemic has strikingly
high mortality rate with hypercoagulability state being part of the imputed mechanisms. We …

Background The coronavirus disease 2019 (COVID‐19) shows high morbidity and mortality,
particularly in patients with concomitant cardiovascular diseases. Some of these patients are …

Although COVID-19 disease primarily affects the respiratory system, it has been seen in
many studies that it causes thromboembolic (TE) events in many tissues and organs. So …

Data on the prognosis of patients treated with oral anticoagulation (OAC) prior to hospital
admission for COVID-19 remains controversial and insufficient. Therefore, we endeavored to …